1. Home
  2. YDKG vs SILO Comparison

YDKG vs SILO Comparison

Compare YDKG & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yueda Digital Holding Class A Ordinary Share

YDKG

Yueda Digital Holding Class A Ordinary Share

N/A

Current Price

$1.04

Market Cap

4.9M

ML Signal

N/A

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.38

Market Cap

4.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDKG
SILO
Founded
2005
2010
Country
China
United States
Employees
N/A
N/A
Industry
Advertising
Apparel
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YDKG
SILO
Price
$1.04
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
140.0K
168.2K
Earning Date
03-06-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2175.52
N/A
52 Week Low
$0.81
$0.33
52 Week High
$669.00
$2.09

Technical Indicators

Market Signals
Indicator
YDKG
SILO
Relative Strength Index (RSI) N/A 45.06
Support Level N/A $0.37
Resistance Level N/A $0.40
Average True Range (ATR) 0.00 0.02
MACD 0.00 0.01
Stochastic Oscillator 0.00 55.44

Price Performance

Historical Comparison
YDKG
SILO

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: